Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Wave Life Sciences (WVE) Accumulated Depreciation & Amortization (2016 - 2025)

Wave Life Sciences filings provide 12 years of Accumulated Depreciation & Amortization readings, the most recent being $49.5 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 6.89% to $49.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.5 million, a 6.89% increase, with the full-year FY2025 number at $49.5 million, up 6.89% from a year prior.
  • Accumulated Depreciation & Amortization hit $49.5 million in Q4 2025 for Wave Life Sciences, up from $46.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $49.5 million in Q4 2025 to a low of $32.2 million in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $42.7 million (2023), compared with a mean of $41.7 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 29.47% in 2021 and later grew 6.89% in 2025.
  • Wave Life Sciences' Accumulated Depreciation & Amortization stood at $32.2 million in 2021, then rose by 17.42% to $37.8 million in 2022, then rose by 12.85% to $42.7 million in 2023, then grew by 8.48% to $46.3 million in 2024, then increased by 6.89% to $49.5 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $49.5 million (Q4 2025), $46.3 million (Q4 2024), and $42.7 million (Q4 2023) per Business Quant data.